Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1
Open Access
- 1 May 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 103 (1) , 1057-1066
- https://doi.org/10.1111/j.1476-5381.1991.tb12300.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release.Journal of Clinical Investigation, 1990
- Interleukin 1 inhibits contraction of vascular smooth muscle.Journal of Clinical Investigation, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.The Journal of Experimental Medicine, 1987
- Inducible interleukin-1 gene expression in human vascular smooth muscle cells.Journal of Clinical Investigation, 1986
- Mitogenic effect of bradykinin and of des-Arg9-bradykinin on cultured fibroblastsLife Sciences, 1986
- Multiple biological activities of human recombinant interleukin 1.Journal of Clinical Investigation, 1986
- Pharmacology of kinins: Their relevance to tissue injury and inflammationGeneral Pharmacology: The Vascular System, 1983
- De novo formation of vascular receptors for bradykininCanadian Journal of Physiology and Pharmacology, 1978
- Receptors for bradykinin in rabbit aortaeCanadian Journal of Physiology and Pharmacology, 1977